Showing results (1371-1380 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|December 4, 2003
Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjectsJong-Hoon Kim, Hee-Jung ByunClinical Neuropharmacology|June 11, 2004
Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infectionNuray Atasoy, Yucel Ustundag, Numan Konuk, et al.Clinical Neuropharmacology|June 11, 2004
Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson diseaseV Mesnage, J L Houeto, A M Bonnet, et al.Clinical Neuropharmacology|June 11, 2004
Variation in the dopaminergic response during the day in Parkinson diseaseAlessandra Monge, Fabio Viselli, Fabrizio Stocchi, et al.Clinical Neuropharmacology|June 11, 2004
Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson diseaseN Van Blercom, A Lasa, K Verger, et al.Clinical Neuropharmacology|June 11, 2004
Phyto-oestrogens in the prophylaxis of menstrual migraineF Ferrante, E Fusco, P Calabresi, et al.Clinical Neuropharmacology|June 11, 2004
Acetylcholinesterase and its inhibition in Alzheimer diseaseRoger M Lane, Miia Kivipelto, Nigel H GreigClinical Neuropharmacology|January 1, 1994
Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitionersJ P Gachoud, P Dick, M KöhlerClinical Neuropharmacology|January 1, 1983
Cortical reflex myoclonus responds to intravenous lisurideJ A Obeso, J C Rothwell, N P Quinn, et al.Clinical Neuropharmacology|March 1, 1983
Changes in extrapyramidal symptoms following anticholinergic drug withdrawalA Perenyi, G Gardos, I Samu, et al.Pageof 237